Capital Fund Management (CFM)
KITE

Capital Fund Management (CFM)’s Kite Pharma, Inc. KITE Stock Holding History

Capital Fund Management (CFM)’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-15,893
Closed -$2.86M – 2089
2017
Q3 		$2.86M Sell
15,893
-22,981
-59% -$3.2M 0.02% 679
2017
Q2 		$4.03M Buy
+38,874
New +$3.17M 0.03% 534
2016
Q3 		– Sell
-4,981
Closed -$249K – 1902
2016
Q2 		$249K Buy
+4,981
New +$245K ﹤0.01% 1381
2016
Q1 		– Sell
-40,504
Closed -$2.5M – 2022
2015
Q4 		$2.5M Buy
+40,504
New +$2.85M 0.03% 612

Capital Fund Management (CFM)'s KITE Position: Q4 2017 in Review

Capital Fund Management (CFM) sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 15,893 shares — an estimated $2.86M sold.

Capital Fund Management (CFM) first reported a position in KITE in Q4 2015 and held it in 4 quarters. The position peaked at $4.03M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Capital Fund Management (CFM) reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 15,893 Kite Pharma, Inc. shares in Q4 2017, an estimated $2.86M.
  • Capital Fund Management (CFM) first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 4 quarters.
  • Capital Fund Management (CFM)'s Kite Pharma, Inc. position peaked at $4.03M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2017, filed 9 Feb 2018.